Cases
Cases 1 - 10 of 10
INTRA-CELLULAR THERAPIES, INC. v. SANDOZ INC.
as 3:2024cv04327
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: SANDOZ INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. ALKEM LABORATORIES LTD.
as 3:2024cv04312
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al
as 3:2024cv04317
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: HETERO USA, INC., HETERO LABS LTD. UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. MSN LABORATORIES PRIVATE LTD.
as 3:2024cv04325
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: MSN LABORATORIES PRIVATE LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2024cv04330
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. DR. REDDYS LABORATORIES, INC. et al
as 3:2024cv04314
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. AUROBINDO PHARMA LTD. et al
as 3:2024cv04264
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Intra-Cellular Therapies, Inc. v. Matal We have downloadable decisions or orders for this case
as 1:2017cv00776
Plaintiff: Intra-Cellular Therapies, Inc.
Defendant: Honorable Joseph Matal
Cause Of Action: 35 U.S.C. § 154
Pakdeljam v. Intra-Cellular Therapies, Inc. et al
as 1:2017cv03197
Defendant: Lawrence J. Hineline, Intra-Cellular Therapies, Inc., Sharon Mates and others
Plaintiff: Joshua Pakdeljam
Cause Of Action: 15 U.S.C. § 78 m(a) Securities Exchange Act
Yoo v. Intra-Cellular Therapies, Inc. et al
as 1:2017cv02928
Defendant: Lawrence J. Hineline, Intra-Cellular Therapies, Inc., Sharon Mates and others
Plaintiff: Kevin Yoo
Cause Of Action: 15 U.S.C. § 78 m(a) Securities Exchange Act

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?